Tandem Diabetes Care Inc. (TNDM)
19.25
-0.56 (-2.83%)
At close: Mar 28, 2025, 3:59 PM
19.32
0.39%
After-hours: Mar 28, 2025, 06:50 PM EDT
Tandem Diabetes Care Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 940.2M | 747.72M | 801.22M | 702.8M | 498.83M | 362.31M | 183.87M | 107.6M | 84.25M | 72.85M | 49.72M | 29.01M | 2.47M | n/a |
| Cost of Revenue | 450.63M | 380.03M | 388.23M | 326.58M | 238.31M | 168.09M | 94.04M | 63.51M | 60.66M | 46.27M | 34.47M | 22.84M | 3.82M | n/a |
| Gross Profit | 489.57M | 367.69M | 412.99M | 376.21M | 260.52M | 194.21M | 89.82M | 44.09M | 23.59M | 26.58M | 15.25M | 6.17M | -1.35M | n/a |
| Operating Income | -99.13M | -233.23M | -61.81M | 8.81M | -7.96M | -16.72M | -44.63M | -62.94M | -78.05M | -69M | -75.66M | -49.43M | -33.05M | -24.21M |
| Interest Income | 17.99M | 22.86M | 6.06M | 674K | 1.57M | 3.27M | 1.46M | 239K | 296K | 337K | 112K | 6.64K | 2.42K | 13.66K |
| Pretax Income | -91.87M | -220.25M | -92.85M | 15.9M | -36.28M | -24.6M | -122.56M | -73.03M | -83.46M | -72.41M | -79.45M | -63.14M | -33.02M | -25.51M |
| Net Income | -96.03M | -222.61M | -94.59M | 15.57M | -34.38M | -24.75M | -122.61M | -73.03M | -83.45M | -72.42M | -79.52M | -63.14M | -33.02M | -25.51M |
| Selling & General & Admin | 389.82M | 352.5M | 335.68M | 261.51M | 204.9M | 165.74M | 105.23M | 86.38M | 82.83M | 78.62M | 75.12M | 44.52M | 22.69M | 15.95M |
| Research & Development | 198.88M | 169.67M | 139.11M | 92.05M | 63.57M | 45.2M | 29.23M | 20.66M | 18.81M | 16.96M | 15.79M | 11.08M | 9.01M | 8.26M |
| Other Expenses | n/a | 78.75M | -4K | n/a | n/a | -7.88M | -77.93M | -10.08M | -5.41M | -3.4M | -3.79M | 44.52M | 22.69M | n/a |
| Operating Expenses | 588.7M | 600.92M | 474.8M | 353.56M | 268.48M | 210.93M | 134.45M | 107.04M | 101.64M | 95.58M | 90.91M | 55.6M | 31.7M | 24.21M |
| Interest Expense | 5.51M | 9.88M | 4.31M | 4.31M | 12.15M | 78K | 7.58M | 11.34M | 5.71M | 3.74M | 3.9M | 4.71M | 2.53M | 542.17K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1.5M | 700K | 68K | n/a |
| Cost & Expenses | 1.04B | 980.95M | 863.03M | 680.15M | 506.79M | 379.03M | 228.5M | 170.54M | 162.3M | 141.85M | 125.39M | 78.44M | 35.52M | 24.21M |
| Income Tax | 4.16M | 2.36M | 1.74M | 335K | -1.9M | 149K | 51K | 8K | -15K | 10K | 71K | 4.71M | 2.53M | 542.17K |
| Shares Outstanding (Basic) | 65.45M | 64.9M | 64.15M | 63M | 60.99M | 58.51M | 48.13M | 5.68M | 3.06M | 2.89M | 2.33M | 294.2K | 1.25M | 1.25M |
| Shares Outstanding (Diluted) | 65.45M | 64.97M | 64.15M | 64.35M | 60.99M | 58.51M | 48.13M | 5.68M | 3.06M | 2.89M | 2.33M | 294.2K | 1.25M | 1.25M |
| EPS (Basic) | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 | -0.42 | -2.55 | -12.86 | -27.3 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| EPS (Diluted) | -1.47 | -3.43 | -1.47 | 0.24 | -0.56 | -0.42 | -2.55 | -12.86 | -27.3 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| EBITDA | -99.13M | -194.66M | -72.31M | 36.5M | -13.03M | -18.45M | -109.16M | -54.82M | -72.27M | -63.84M | -71.16M | -55.26M | -28.46M | -22.92M |
| Depreciation & Amortization | n/a | 15.71M | 14.33M | 13.85M | 10.45M | 6.07M | 5.82M | 6.87M | 5.49M | 4.83M | 4.39M | 3.17M | 2.03M | 1.28M |